Q: Hi. Any news on what happened with GUD in the last 20 minutes? Thanks
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: I completely understand your support for Johnathan Goodman at Knight as his history is beyond impressive. However, I think Mr. Jakobsohn's proposal asks some significant questions that, as a shareholder, I would like to hear answers for. It does make me uncomfortable that his family company got involved in four deals and he will benefit more than if he had Knight involved. That seems like a legitimate concern as is the puny revenues generated in four years since Knight's launch. Conversely, Knight provided Medisen the opportunity to thrive and succeed and it is not the first time I have seen beneficiaries conveniently forget who helped them become successful once they have achieved momentum and no longer need their benefactor.
Ultimately, I do hope this exercise will help Goodman see some valid points in Jakobsohn's presentation and diversify his board and spend some cash. The articles that have appeared about Goodman detail his bargaining savvy but who would want to deal with him when it is public knowledge he has a desire to buy for nothing... I wish he would forget about his famous "grandchildren" analogy and show the investors who have supported his financings and bought the stock at $10 plus that he can still discover companies with potential and make mutually beneficial deals so Knight can thrive and grow.
I doubt Jakobsohn's proposal will go anywhere but perhaps it will reinforce to Goodman that his approach could be a little more "in the present" to his many investors/supporters.
I have a bad case of FOMO when it comes to Knight. If I liquidate part or all of my shares, I stress about Goodman making a blockbuster deal the next day!!
Would you agree with anything I have said and please provide an opinion on any value in the dissenting proposal.
Thanks.
Ultimately, I do hope this exercise will help Goodman see some valid points in Jakobsohn's presentation and diversify his board and spend some cash. The articles that have appeared about Goodman detail his bargaining savvy but who would want to deal with him when it is public knowledge he has a desire to buy for nothing... I wish he would forget about his famous "grandchildren" analogy and show the investors who have supported his financings and bought the stock at $10 plus that he can still discover companies with potential and make mutually beneficial deals so Knight can thrive and grow.
I doubt Jakobsohn's proposal will go anywhere but perhaps it will reinforce to Goodman that his approach could be a little more "in the present" to his many investors/supporters.
I have a bad case of FOMO when it comes to Knight. If I liquidate part or all of my shares, I stress about Goodman making a blockbuster deal the next day!!
Would you agree with anything I have said and please provide an opinion on any value in the dissenting proposal.
Thanks.
Q: Time for tax loss selling? How much chance is there of this stock going higher in a month? Related to this is , at this point, is there any sense in tax loss selling right now, rather than holding until the end of they year, collect the dividend and then sell, if it is still down.
thanks
thanks
Q: comments on the quarter please??
Q: how do you feel about Savaria at this point - buy more - hold what you currently own or sell what you have - regards - Karen
Q: Peter; I’m trying to find the next dividend info on FSZ re ex-date etc. Thanks. Rod
Q: Hello 5i team,
I was looking at the GUD chart and noticed a very high volume of trading in the last week. The last time there was any volume this comparable was 2 years ago.
Is there anything news wise going on with Knight Therapeutics?
Andrew
I was looking at the GUD chart and noticed a very high volume of trading in the last week. The last time there was any volume this comparable was 2 years ago.
Is there anything news wise going on with Knight Therapeutics?
Andrew
Q: Good Morning,
Should we be picking away at NFI for a long term RESP hold?? Or just stay away from a falling knife? Thanks
Should we be picking away at NFI for a long term RESP hold?? Or just stay away from a falling knife? Thanks
Q: Can you explain the sell-off this morning? The results seemed pretty decent!
Q: Can you please comment on WSP earnings and Bureau fines them $4 million.
Thanks for the great service
Hector
Thanks for the great service
Hector
Q: Hi team,
What are your thoughts on this company's earnings released yesterday? As they approach the opening of the new plant in Q3 of this year,should it's stock price pick up momentum?I am down 20% on it over the last 24 months and find the stock price very volatile.
Many thanks,
Jean
What are your thoughts on this company's earnings released yesterday? As they approach the opening of the new plant in Q3 of this year,should it's stock price pick up momentum?I am down 20% on it over the last 24 months and find the stock price very volatile.
Many thanks,
Jean
Q: Hi, Constellation's COO Mr Miller also announced an ASPD agreement for acuisition/disposal of his company shares but at a much larger scale of 10,000 shares a week for price range above $1,000 and below $800. It could be some sort of management plan approved for its top executives/large holders to generate personal liquidity. But, how do you view it from investors' perspective ? There could by as well more of these disclosures in the future. Would such initiatives not put a pressure/cap on stock price ? Thanks
Q: Hi, Could you please comment on the earnings release from this morning. Sounds upbeat !! What do you think of their plan to double Sales with higher margins over 5 years ? Do you believe, company is back on track after repeated misses ? Thanks
Q: With the news this morning that WSP is to pay 4 B in fines to the Quebec government is this time to sell??
Q: Not a question just a statement. Here is a reminder for us long term holders of Knight Therapeutics on what the investment horizon may be.
"For investors, if their investment horizon is not their grandchildren, we are not the right company for them. Paladin had 19 years of record revenues but for 12 of those years, our stock was flat. It took us 19 years to become an overnight success." - Jonathan Ross Goodman
"For investors, if their investment horizon is not their grandchildren, we are not the right company for them. Paladin had 19 years of record revenues but for 12 of those years, our stock was flat. It took us 19 years to become an overnight success." - Jonathan Ross Goodman
Q: Now that the quarterly results are out, what is the buy argument vs the sell argument when it comes to PBH?
Q: I still see considerable upside here looking out 1-2 years. What are the biggest risks facing the company?
Q: Comments on NFI results? Where do these results leave your updated opinion. I believe I saw a nice dividend increase but would like your take.
Q: Please comment on quarterly results when you get a chance.
Q: I didn’t see Syz in any of the portfolios, is it removed from the list? Thanks